Despite the excellent prognosis of most patients with small breast cancers, a small number of women still die from tumours of 1 to 14 mm a few years after diagnosis. When searching for features that are common to these rare fatal cancers, neither axillary node status nor histologic malignancy grade could reliably discriminate fatal cancers from those with excellent prognosis. We have found the mammographic image to be a reliable reflection of breast structure, although it tends to simplify the histological heterogeneity of breast cancer to five mammographic tumour features (Figure 1) [2]. Analysis of these features shows them to be reliable additional prognostic tools for predicting the long-term outcome of early breast cancers [2–4].
Although axillary node status and histological malignancy grade are established and reliable prognostic factors in tumours larger than 20 mm, the predictive value of these factors is reduced at sizes under 15 mm. Tumours that present with casting type calcifications on the mammogram have exhibited a surprisingly poor outcome, even when they are node negative, which demonstrates the prognostic value of this particular mammographic tumour feature when estimating patient outcome. Also, the diminished reliability of the histological malignancy grade was demonstrated in a series consisting of 440 consecutive cases of 1 to 9 mm breast cancer in women aged 40 to 69 years and followed up for as long as 26 years. There was a significantly poorer long-term survival in women with grade 2 invasive breast cancer than in those with 1 to 9 mm grade 3 breast cancers. However, the addition of the mammographic tumour features allows us to divide the grade 2 tumours into two subgroups that have vastly different outcomes. Women lacking calcifications had 100% long-term survival, whereas the association of extensive, grade 3 in situ breast cancer presenting on the mammogram as casting type calcifications with 1 to 9 mm grade 2 invasive breast cancer led to a surprisingly poor long-term survival [2–4] (Figure 2).
The integration of mammographic tumour features into the TMN staging system should enable practising physicians to distinguish more accurately between the 1 to 14 mm breast cancers with extremely good long-term prognosis and those cases with unexpectedly poor prognosis, allowing them to use more specifically targeted therapy and to avoid overtreatment.
The 26-year survival rates of women with 1 to 9 mm and 10 to 14 mm invasive breast cancers associated with casting type calcifications were 49% and 54%, respectively. This finding suggests that 1 to 14 mm breast cancers that are associated with casting type calcifications should belong to a more advanced stage category that reflects their clinical behaviour. The casting type calcifications are found within the abnormal, closely packed, contorted, newly formed ducts, which we consider to be duct-forming invasive carcinoma and have termed 'neoductgenesis' [2, 3]. It appears that vascular intrusion may occur during this process of neoductgenesis, leading to histologically demonstrable extensive lymphatic and/or haematogenous spread. On the other hand, stellate/spiculated 1 to 9 mm tumours without associated calcification, which comprised the largest group (50%) in this size range, had the greatest long-term survival (99%). After exclusion of 1 to 9 mm cancers associated with casting type calcifications, the remaining cancers have extremely good prognosis when they are treated with surgery alone. Adjuvant therapeutic regimens offer little to no benefit to these patients and have the potential for causing harm [2, 5].
Summary
The mammographic tumour features can serve as independent predictors of long-term outcome in screen-detected 1 to 14 mm invasive breast cancers.